These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8792922)

  • 1. Lack of subsensitivity to mizolastine over 8-week treatment.
    Bousquet J; Chanal I; Murrieta M; Stalla-Bourdillon A
    Allergy; 1996 Apr; 51(4):251-6. PubMed ID: 8792922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of histamine-induced skin wheal and flare after 5 days of mizolastine.
    Pinquier JL; Caplain H; Cabanis MJ; Dubruc C; Stalla-Bourdillon A; Rosenzweig P
    J Clin Pharmacol; 1996 Jan; 36(1):72-8. PubMed ID: 8932546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model.
    Deschamps C; Dubruc C; Mentre F; Rosenzweig P
    Clin Pharmacol Ther; 2000 Dec; 68(6):647-57. PubMed ID: 11180025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral and cellular responses to histamine and pollen allergen in a skin chamber model: effect of mizolastine.
    Michel L; Murrieta-Aguttes M; Jean-Louis F; Levy D; Dubertret L
    Ann Allergy Asthma Immunol; 2000 Jul; 85(1):64-9. PubMed ID: 10923607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative activity of cetirizine and mizolastine on histamine-induced skin wheal and flare responses at 24 h.
    Purohit A; Mélac M; Pauli G; Frossard N
    Br J Clin Pharmacol; 2002 Mar; 53(3):250-4. PubMed ID: 11874388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of mizolastine in seasonal allergic rhinitis. The Rhinase Study Group.
    Leynadier F; Bousquet J; Murrieta M; Attali P
    Ann Allergy Asthma Immunol; 1996 Feb; 76(2):163-8. PubMed ID: 8595536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine.
    Frèche C; Leynadier F; Horak F; Hide D; Gracia FD; Goos M; Bachert C; Horvath A; Antosova E; Verrecchia M; Soussen PB
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):304-10. PubMed ID: 12269652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria.
    Brostoff J; Fitzharris P; Dunmore C; Theron M; Blondin P
    Allergy; 1996 May; 51(5):320-5. PubMed ID: 8836336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of mizolastine with loratadine in the treatment of perennial allergic rhinitis.
    Bellioni P; Catalano B; Cervellera G; Filiaci F; Mira E; Carraro A
    Rhinology; 1996 Jun; 34(2):101-4. PubMed ID: 8876072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mizolastine therapy also has an effect on nasal blockade in perennial allergic rhinoconjunctivitis. RIPERAN Study Group.
    Bachert C; Brostoff J; Scadding GK; Tasman J; Stalla-Bourdillon A; Murrieta M
    Allergy; 1998 Oct; 53(10):969-75. PubMed ID: 9821477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers.
    Rosenzweig P; Caplain H; Chaufour S; Ulliac N; Cabanis MJ; Thebault JJ
    Br J Clin Pharmacol; 1995 Nov; 40(5):459-65. PubMed ID: 8703650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
    Dubertret L; Murrieta Aguttes M; Tonet J
    J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group.
    Leynadier F; Duarte-Risselin C; Murrieta M
    Eur J Dermatol; 2000; 10(3):205-11. PubMed ID: 10725819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can an antihistamine delay appearance of hay fever symptoms when given prior to pollen season?
    Stern MA; Darnell R; Tudor D
    Allergy; 1997 Apr; 52(4):440-4. PubMed ID: 9188928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
    Grant JA; Riethuisen JM; Moulaert B; DeVos C
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mizolastine: antihistaminic activity from preclinical data to clinical evaluation.
    Simons FE
    Clin Exp Allergy; 1999 Mar; 29 Suppl 1():3-8. PubMed ID: 10209699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative activity of antihistamines on area under dose-response curve from histamine-induced wheal and flare responses in human skin].
    Wang RQ; Zhang HY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):634-8. PubMed ID: 15663222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of subsensitivity to loratadine during long-term dosing during 12 weeks.
    Bousquet J; Chanal I; Skassa-Brociek W; Lemonier C; Michel FB
    J Allergy Clin Immunol; 1990 Aug; 86(2):248-53. PubMed ID: 1974561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of cardiac repolarization in healthy volunteers performed with mizolastine, a new H1-receptor antagonist.
    Chaufour S; Caplain H; Lilienthal N; L'héritier C; Deschamps C; Dubruc C; Rosenzweig P
    Br J Clin Pharmacol; 1999 May; 47(5):515-20. PubMed ID: 10336575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine.
    Chosidow O; Dubruc C; Danjou P; Fuseau E; Espagne E; Bianchetti G; Thenot JP; Herson S; Rosenzweig P; Revuz J
    Eur J Clin Pharmacol; 1996; 50(4):327-33. PubMed ID: 8803528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.